Position in XERS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$656,013
+$67,673 QoQ
Shares Held
82,830
-18.3% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#99
of 239 holders
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names. XERS ranks #8 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
55,201 | $2,264,897 | |
| 2 | ZTS |
Zoetis Inc.
|
18,470 | $1,327,254 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
259,512 | $1,092,545 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
90,210 | $902,100 | |
| 5 | LQDA |
Liquidia Corp
|
10,098 | $805,113 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
11,219 | $717,455 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
39,241 | $704,768 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
This page
|
82,830 | $656,013 |
All Filings in XERS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $656,013 | 82,830 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $588,340 | 101,438 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $272,120 | 34,665 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $559,348 | 68,716 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $291,043 | 62,322 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $761,655 | 138,735 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $168,967 | 49,843 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $77,947 | 27,350 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,362,741 | 605,663 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $25,881 | 11,711 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $978,227 | 416,267 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $709,089 | 381,231 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $87,023 | 33,215 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $515,120 | 316,025 | Shares | Sole | 2023-05-12 | |
| 2022-09-30 | $78,146 | 50,094 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $68,739 | 44,636 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $300,305 | 117,307 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $326,026 | 111,272 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||